Novonesis A/S (OTC:NVZMY - Get Free Report)'s stock price shot up 1.8% during mid-day trading on Friday . The company traded as high as $74.20 and last traded at $72.98. 46,047 shares were traded during trading, an increase of 33% from the average session volume of 34,722 shares. The stock had previously closed at $71.67.
Novonesis A/S Trading Up 0.6%
The stock's 50-day moving average is $65.68 and its 200-day moving average is $60.48. The stock has a market cap of $34.60 billion, a price-to-earnings ratio of 46.76, a P/E/G ratio of 2.79 and a beta of 0.92.
Novonesis A/S Company Profile
(
Get Free Report)
Novonesis A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.
Featured Articles
Before you consider Novozymes A/S, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novozymes A/S wasn't on the list.
While Novozymes A/S currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
